79 related articles for article (PubMed ID: 3438314)
1. [Kinetics of liberation from suppository bases of phenobarbital acid and sodium and a semi-synthetic glyceride (Witepsol H 15). II. Suppositories after storage].
Lasserre Y; Peneva MB; Jacob M; Puech A; Sabatier R
Pharm Acta Helv; 1987; 62(10-11):287-91. PubMed ID: 3438314
[No Abstract] [Full Text] [Related]
2. [Kinetics of release from suppositories formulated with phenobarbital acid or sodium, and semi-synthetic glyceride (Witepsol H 15). I. Freshly prepared suppositories].
Lasserre Y; Peneva B; Jacob M; Puech A
Pharm Acta Helv; 1984; 59(3):77-9. PubMed ID: 6718438
[No Abstract] [Full Text] [Related]
3. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
Pasich J; Drobnicka B; Kasprzyk A
Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
[TBL] [Abstract][Full Text] [Related]
5. [Liberation of active substances from suppository bases. II. In vivo studies of phenobarbital suppositories].
Grzesiczak A; Ludwicki H; Ostrowska E
Acta Pol Pharm; 1981; 38(4):493-7. PubMed ID: 7331837
[No Abstract] [Full Text] [Related]
6. Studies on aminophenazone and phenobarbital release from suppositories prepared on different bases.
Piasecka H; Zakrzewski Z
Pol J Pharmacol Pharm; 1976; 28(2):199-203. PubMed ID: 934948
[TBL] [Abstract][Full Text] [Related]
7. [On the action of various factors on the liberation from suppositories (author's transl)].
Bornschein M; Grohmann A; Voigt R
Pharmazie; 1980 Dec; 35(12):772-6. PubMed ID: 7208579
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic studies of pregabalin suppositories based on pharmacological research.
Yajima R; Matsumoto K; Yokono K; Watabe Y; Enoki Y; Taguchi K; Ise Y; Katayama S; Kizu J
J Pharm Pharmacol; 2019 May; 71(5):746-752. PubMed ID: 30515815
[TBL] [Abstract][Full Text] [Related]
9. [Production technology and in vitro study of rectal suppositories containing chloroquine phosphate].
Regdon Géza JR; Schirm I; Pittmann A; Regdon G
Acta Pharm Hung; 1995 Mar; 65(2):45-50. PubMed ID: 7793289
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of Phenobarbital in Microenema Via Macy Catheter Versus Suppository.
Lam YW; Lam A; Macy B
J Pain Symptom Manage; 2016 Jun; 51(6):994-1001. PubMed ID: 27112311
[TBL] [Abstract][Full Text] [Related]
11. [Rectal absorption of phenobarbital in children as affected by different vehicles].
Heimann G; Neuwald F; Gladtke E
Arzneimittelforschung; 1978; 28(6):1023-6. PubMed ID: 581999
[TBL] [Abstract][Full Text] [Related]
12. In vitro release of meclozine hydrochloride from lipophilic suppository bases with or without tensides.
Bećirević M; Petricić V; Kallay N
Pharmazie; 1984 Dec; 39(12):828-30. PubMed ID: 6531391
[TBL] [Abstract][Full Text] [Related]
13. [Acetaminophen-containing suppositories in vitro and in vivo].
Regdon G; Szikszay M; Gebri G; Regdon G
Acta Pharm Hung; 1994 Mar; 64(2):45-9. PubMed ID: 8017207
[TBL] [Abstract][Full Text] [Related]
14. Release of pyrazolone derivatives from suppositories formulated with hydrophilic and hydrophobic bases.
Bećirević M; Petricić V
Pharmazie; 1986 May; 41(5):338-40. PubMed ID: 3737665
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical studies of levothyroxine sodium hydrate suppository provided as a hospital preparation.
Hamada Y; Masuda K; Okubo M; Nakasa H; Sekine Y; Ishii I
Biol Pharm Bull; 2015; 38(4):625-8. PubMed ID: 25832643
[TBL] [Abstract][Full Text] [Related]
16. [A comparative pharmacokinetic study for tablet and suppository formulations of a combination product of caffeine, ethaverine, propyphenazone, paracetamol and phenobarbital (author's transl)].
Maier-Lenz H; Ringwelski L; Windorfer A
Arzneimittelforschung; 1981; 31(1):105-9. PubMed ID: 7194086
[TBL] [Abstract][Full Text] [Related]
17. Release property of progesterone from a mixed-base suppository consisting of Witepsol W35 and Witepsol E85.
Iwata M; Komiya S; Nakamura K; Kiuchi M; Andoh N; Hirahara F; Maitani Y; Takayama K
Drug Dev Ind Pharm; 2001 Nov; 27(10):1039-45. PubMed ID: 11794806
[TBL] [Abstract][Full Text] [Related]
18. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
[TBL] [Abstract][Full Text] [Related]
19. [Characterization of storage-induced release reductions in suppositories (author's transl)].
Voigt R; Grohmann A; Bornschein M
Pharmazie; 1981 Sep; 36(9):631-3. PubMed ID: 7301905
[TBL] [Abstract][Full Text] [Related]
20. Enhanced absorption of phenobarbital from suppositories containing amino acid and choline salts of phenobarbital.
Iwaoku R; Nakano M
Chem Pharm Bull (Tokyo); 1987 Nov; 35(11):4645-9. PubMed ID: 3442899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
